Revolutionizing Alzheimer's disease and clinical trials through biomarkers

The Alzheimer's Association's Research Roundtable met in May 2014 to explore recent progress in developing biomarkers to improve understanding of disease pathogenesis and expedite drug development. Although existing biomarkers have proved extremely useful for enrichment of subjects in clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattsson, Niklas, Carrillo, Maria C., Dean, Robert A., Devous, Michael D., Nikolcheva, Tania, Pesini, Pedro, Salter, Hugh, Potter, William Z., Sperling, Reisa S., Bateman, Randall J., Bain, Lisa J., Liu, Enchi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Diagnostic Assessment & Prognosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879481/
https://www.ncbi.nlm.nih.gov/pubmed/27239522
http://dx.doi.org/10.1016/j.dadm.2015.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879481/
https://www.ncbi.nlm.nih.gov/pubmed/27239522
http://dx.doi.org/10.1016/j.dadm.2015.09.001

Ejemplares similares